ITGAL and carcinoma: ICAM-1 on target cells binds to its cognate receptor LFA-1 (ITGAL/ITGB2) on effector lymphocytes (e.g., CTLs and NK cells), strengthening the interaction between the cytotoxic killer cells and carcinoma target cells (Figure 4).